Hantz Financial Services’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $640K | Buy |
11,338
+5,883
| +108% | +$343K | 0.01% | 580 |
|
|
2025
Q4 | $324K | Buy |
5,455
+3,900
| +251% | +$212K | ﹤0.01% | 696 |
|
|
2025
Q3 | $84K | Buy |
1,555
+499
| +47% | +$28.5K | ﹤0.01% | 1027 |
|
|
2025
Q2 | $58K | Buy |
1,056
+874
| +480% | +$51.5K | ﹤0.01% | 923 |
|
|
2025
Q1 | $13K | Buy |
182
+61
| +50% | +$4.1K | ﹤0.01% | 904 |
|
|
2024
Q4 | $8K | Hold |
121
| – | – | ﹤0.01% | 838 |
|
|
2024
Q3 | $9K | Buy |
121
+43
| +55% | +$3.59K | ﹤0.01% | 801 |
|
|
2024
Q2 | $6K | Hold |
78
| – | – | ﹤0.01% | 841 |
|
|
2024
Q1 | $7K | Sell |
78
-12
| -13% | -$1.07K | ﹤0.01% | 880 |
|
|
2023
Q4 | $9K | Hold |
90
| – | – | ﹤0.01% | 811 |
|
|
2023
Q3 | $8K | Hold |
90
| – | – | ﹤0.01% | 825 |
|
|
2023
Q2 | $8K | Sell |
90
-53
| -37% | -$4.99K | ﹤0.01% | 803 |
|
|
2023
Q1 | $14K | Hold |
143
| – | – | ﹤0.01% | 740 |
|
|
2022
Q4 | $15K | Sell |
143
-41
| -22% | -$3.85K | ﹤0.01% | 702 |
|
|
2022
Q3 | $16K | Sell |
184
-3
| -2% | -$267 | ﹤0.01% | 681 |
|
|
2022
Q2 | $15K | Sell |
187
-29
| -13% | -$2.31K | ﹤0.01% | 689 |
|
|
2022
Q1 | $17K | Sell |
216
-10,845
| -98% | -$907K | ﹤0.01% | 701 |
|
|
2021
Q4 | $977K | Buy |
11,061
+781
| +8% | +$64.4K | 0.03% | 369 |
|
|
2021
Q3 | $795K | Buy |
10,280
+2,379
| +30% | +$188K | 0.03% | 363 |
|
|
2021
Q2 | $659K | Buy |
7,901
+437
| +6% | +$34.6K | 0.02% | 370 |
|
|
2021
Q1 | $564K | Sell |
7,464
-509
| -6% | -$41.6K | 0.02% | 354 |
|
|
2020
Q4 | $699K | Buy |
7,973
+115
| +1% | +$9.12K | 0.03% | 312 |
|
|
2020
Q3 | $598K | Buy |
7,858
+732
| +10% | +$74.1K | 0.03% | 311 |
|
|
2020
Q2 | $879K | Sell |
7,126
-123
| -2% | -$12.2K | 0.05% | 279 |
|
|
2020
Q1 | $613K | Buy |
+7,249
| New | +$625K | 0.04% | 281 |
|
Other funds holding BMRN
VCM
VPM
